These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32228359)

  • 21. Systematic review of the effectiveness of training programs in writing for scholarly publication, journal editing, and manuscript peer review (protocol).
    Galipeau J; Moher D; Skidmore B; Campbell C; Hendry P; Cameron DW; Hébert PC; Palepu A
    Syst Rev; 2013 Jun; 2():41. PubMed ID: 23773340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ResearchGate is no longer reliable: leniency towards ghost journals may decrease its impact on the scientific community.
    Memon AR
    J Pak Med Assoc; 2016 Dec; 66(12):1643-1647. PubMed ID: 27924967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IOM: Curbing fake drugs will require national tracking and global teamwork.
    Kuehn BM
    JAMA; 2013 Apr; 309(13):1333-4. PubMed ID: 23549559
    [No Abstract]   [Full Text] [Related]  

  • 24. Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population.
    Jewell JS; Bemis EA; Black JC
    J Addict Med; 2024 Jul-Aug 01; 18(4):466-469. PubMed ID: 38832681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Academic nightmares: Predatory publishing.
    Van Nuland SE; Rogers KA
    Anat Sci Educ; 2017 Jul; 10(4):392-394. PubMed ID: 27911990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global scenario of counterfeit antimalarials: A potential threat.
    Arora T; Sharma S
    J Vector Borne Dis; 2019; 56(4):288-294. PubMed ID: 33269727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All the players in the game: driving home the global commitment for legitimate drugs.
    Babyar J
    Drug Dev Ind Pharm; 2018 Nov; 44(11):1868-1870. PubMed ID: 30114946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fake drugs, real concerns: Counterfeit HIV medications and community trust.
    Ware KB; Campbell RD; Turner M
    Res Social Adm Pharm; 2023 Apr; 19(4):686-691. PubMed ID: 36460561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The story of fake impact factor companies and how we detected them.
    Jalalian M
    Electron Physician; 2015; 7(2):1069-72. PubMed ID: 26120416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Producing deceptive actions in sports: The costs of generating head fakes in basketball.
    Güldenpenning I; Weigelt M; Böer NT; Kunde W
    Hum Mov Sci; 2023 Feb; 87():103045. PubMed ID: 36508851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fake drugs, what are we talking about? Counterfeit drugs, informal market, quality of pharmaceutical… Thought from an anthropological study led in Benin].
    Baxerres C
    Bull Soc Pathol Exot; 2014 May; 107(2):121-6. PubMed ID: 24639135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations.
    Rasheed H; Hoellein L; Bukhari KS; Holzgrabe U
    J Pharm Policy Pract; 2019; 12():23. PubMed ID: 31528352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bad medicine in the market.
    Roger B; Boateng K
    World Hosp Health Serv; 2007; 43(3):17-21. PubMed ID: 18269104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment.
    Mackey TK; Liang BA; York P; Kubic T
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):59-67. PubMed ID: 25897059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing good scientific publishing practices: one pharmaceutical company's perspective.
    Dowsett SA; Van Campen LE; Bednar LA
    Curr Med Res Opin; 2010 Jun; 26(6):1249-54. PubMed ID: 20350148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global health equity in United Kingdom university research: a landscape of current policies and practices.
    Gotham D; Meldrum J; Nageshwaran V; Counts C; Kumari N; Martin M; Beattie B; Post N
    Health Res Policy Syst; 2016 Oct; 14(1):76. PubMed ID: 27724907
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.